Kolibri
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
111 Avenue De France, Paris, Ile-de-Fran...Website
www.kolibrilab.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Kolibri
Kolibri Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kolibri your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Kolibri
Kolibri, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kolibri had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Kolibri has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Kolibri recently announced quarterly report
Check if Kolibri has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Kolibri launches new products
Check out if Kolibri is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Kolibri as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Kolibri is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kolibri is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kolibri.
Kolibri Tech Stack
A closer look at the technologies used by Kolibri
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kolibri
Kolibri revolutionises the way we grow cells at scale using acoustic waves. Showing 100x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies. Being cell-agnostic and scalable, our process has significant potential across a range of hig... Read More
